These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 23332108)

  • 1. Low-molecular-weight heparin inhibits plasma thrombin generation via direct targeting of factor IXa: a reply to rebuttal.
    Buyue Y; Misenheimer TM; Sheehan JP
    J Thromb Haemost; 2013 Mar; 11(3):565-6. PubMed ID: 23332108
    [No Abstract]   [Full Text] [Related]  

  • 2. Low molecular weight heparin inhibits plasma thrombin generation via direct targeting of factor IXa: a rebuttal.
    Hemker HC; Béguin S
    J Thromb Haemost; 2013 Mar; 11(3):564. PubMed ID: 23289967
    [No Abstract]   [Full Text] [Related]  

  • 3. Low molecular weight heparin inhibits plasma thrombin generation via direct targeting of factor IXa: contribution of the serpin-independent mechanism.
    Buyue Y; Misenheimer TM; Sheehan JP
    J Thromb Haemost; 2012 Oct; 10(10):2086-98. PubMed ID: 22905983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interindividual variability of in vitro response to anticoagulants.
    Samama MM
    Thromb Res; 2011 Jan; 127(1):1. PubMed ID: 21075429
    [No Abstract]   [Full Text] [Related]  

  • 5. Inter-individual variability of effect of 7 low molecular weight antithrombin-dependent anticoagulants studied in vitro with calibrated automated thrombography.
    Hacquard M; Perrin J; Lelievre N; Vigneron C; Lecompte T
    Thromb Res; 2011 Jan; 127(1):29-34. PubMed ID: 20850172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Challenges with heparin-based anticoagulation during cardiopulmonary bypass in children: Impact of low antithrombin activity.
    Manlhiot C; Gruenwald CE; Holtby HM; Brandão LR; Chan AK; Van Arsdell GS; McCrindle BW
    J Thorac Cardiovasc Surg; 2016 Feb; 151(2):444-50. PubMed ID: 26553458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antithrombin levels during pediatric cardiopulmonary bypass: Key to changing a decades-old paradigm for anticoagulation?
    Andropoulos DB; Fraser CD
    J Thorac Cardiovasc Surg; 2016 Feb; 151(2):305-6. PubMed ID: 26578182
    [No Abstract]   [Full Text] [Related]  

  • 8. Activation of blood coagulation at heparin-coated surfaces.
    Blezer R; Fouache B; Willems GM; Lindhout T
    J Biomed Mater Res; 1997 Oct; 37(1):108-13. PubMed ID: 9335355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mode of action of heparin and related drugs.
    Hemker HC; Beguin S
    Semin Thromb Hemost; 1991; 17 Suppl 1():29-34. PubMed ID: 1648791
    [No Abstract]   [Full Text] [Related]  

  • 10. Selective disruption of heparin and antithrombin-mediated regulation of human factor IX.
    Westmark PR; Tanratana P; Sheehan JP
    J Thromb Haemost; 2015 Jun; 13(6):1053-63. PubMed ID: 25851619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of factor IXa inhibition by antithrombin in the presence of unfractionated and low molecular weight heparins and fucoidan.
    Mauray S; de Raucourt E; Talbot JC; Dachary-Prigent J; Jozefowicz M; Fischer AM
    Biochim Biophys Acta; 1998 Sep; 1387(1-2):184-94. PubMed ID: 9748565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antithrombin and heparin cofactor II-mediated inactivation of alpha-thrombin by a synthetic, sulfated mannogalactan.
    Gracher AH; Cipriani TR; Carbonero ER; Gorin PA; Iacomini M
    Thromb Res; 2010 Sep; 126(3):e180-7. PubMed ID: 20553946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. From unfractionated heparin to pentasaccharide: Paradigm of rigorous science growing in the understanding of the in vivo thrombin generation.
    Spadarella G; Di Minno A; Donati MB; Mormile M; Ventre I; Di Minno G
    Blood Rev; 2020 Jan; 39():100613. PubMed ID: 31471127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depolymerized holothurian glycosaminoglycan with novel anticoagulant actions: antithrombin III- and heparin cofactor II-independent inhibition of factor X activation by factor IXa-factor VIIIa complex and heparin cofactor II-dependent inhibition of thrombin.
    Nagase H; Enjyoji K; Minamiguchi K; Kitazato KT; Kitazato K; Saito H; Kato H
    Blood; 1995 Mar; 85(6):1527-34. PubMed ID: 7888673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blocking inhibition of prothrombinase by tissue factor pathway inhibitor alpha: a procoagulant property of heparins.
    Wood JP; Baumann Kreuziger LM; Desai UR; Mast AE
    Br J Haematol; 2016 Oct; 175(1):123-32. PubMed ID: 27301751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coagulation inhibition capacities of low-molecular mass and unfractionated heparin, as determined by thrombin generation.
    Elgue G; Sanchez J; Egberg N; Olsson P
    Thromb Res; 1994 Sep; 75(5):539-49. PubMed ID: 7992254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification and partial characterization of draculin, the anticoagulant factor present in the saliva of vampire bats (Desmodus rotundus).
    Apitz-Castro R; Béguin S; Tablante A; Bartoli F; Holt JC; Hemker HC
    Thromb Haemost; 1995 Jan; 73(1):94-100. PubMed ID: 7740503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In-vitro evaluation of anti-factor IXa aptamer on thrombin generation, clotting time, and viscoelastometry.
    Tanaka KA; Szlam F; Rusconi CP; Levy JH
    Thromb Haemost; 2009 May; 101(5):827-33. PubMed ID: 19404534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fucosylated chondroitin sulfate inhibits plasma thrombin generation via targeting of the factor IXa heparin-binding exosite.
    Buyue Y; Sheehan JP
    Blood; 2009 Oct; 114(14):3092-100. PubMed ID: 19414859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparin coating of tantalum coronary stents reduces surface thrombin generation but not factor IXa generation.
    Blezer R; Cahalan L; Cahalan PT; Lindhout T
    Blood Coagul Fibrinolysis; 1998 Jul; 9(5):435-40. PubMed ID: 9712292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.